[LXRX] YoY Annual Result on 31-Dec-2015 [#FY]

Stock
[LXRX] Lexicon Pharmaceuticals, Inc.
Announcement Date
11-Mar-2016
Financial Year
2015
Quarter
31-Dec-2015 [#FY]
Profit Trend
YoY- 95.33%
Quarter Report
LXRX's Result
LXRX's Financial Summary
View:
Show?
Annual Result
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
Revenue 63,209 90,335 83,337 130,014 22,854 2,222 1,089 96.70%
PBT -120,548 -141,711 -141,429 -4,682 -100,364 -104,126 -110,211 1.50%
Tax 3,508 -12,661 4,511 5,995 -70 -833 -1,971 -
NP -120,548 -129,050 -141,429 -4,682 -100,294 -104,126 -110,211 1.50%
Tax Rate - - - - - - - -
Total Cost 183,757 219,385 224,766 134,696 123,148 106,348 111,300 8.71%
Ratio Analysis
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
NP Margin -190.71 -142.86 -169.71 -3.60 -438.85 -4,686.14 -10,120.39 -48.39%
Per Share
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
EPS -1.14 -1.23 -1.36 -0.05 -1.31 -1.42 -1.58 -5.29%
EPS Diluted -1.14 -1.23 -1.36 -0.05 -1.31 -1.42 -1.58 -5.29%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.